Publications internationales
Nous mettons ici à votre disposition une sélection de publications scientifiques en rapport avec l'immunothérapie IOZK.
Vous pouvez effectuer une sélection par type de tumeur et par méthode à l'aide des filtres ou saisir des termes de recherche.
Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25
New approaches to the development of adenoviral dendritic cell vaccines in melanoma
Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients
Effect of hyperthermia on the apoptosis and proliferation of CaSki cells
Hyperthermia and intravesical therapy: emerging one-two punch for bladder cancer?
Hyperthermia as a treatment for bladder cancer
Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells
An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells
NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment
Dendritic cell-based immunotherapy for prostate cancer
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer
Use of attenuated paramyxoviruses for cancer therapy
Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine
[WT1 peptide pulsed dendritic cell therapy with activated T lymphocytes therapy for advanced cancers]
Palliation of recurrent myxofibrosarcoma with radiotherapy and hyperthermia
Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?